在老年多发性骨髓瘤患者中验证韩国老年医学评估工具:一项多中心研究
Ji Yun Lee1, Sang-A Kim1, Youngil Koh2
1Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Cancer research and treatment
|February 25, 2025
概括
韩国癌症研究小组 Geriatric Score-7 (KG-7) 工具确定了脆弱的老年多发性骨髓瘤患者的严重毒性风险较高,但死亡率不高. 需要进行更大规模的研究来确认其在治疗量身定制中的作用.
科学领域:
- 老年瘤学 老年瘤学
- 血液学 血液学 血液学
- 临床试验方法论 临床试验方法论
背景情况:
- 患有多发性骨髓瘤 (MM) 的老年患者往往有独特的治疗考虑.
- 脆弱性评估对于优化治疗和预防这一群体的不良事件至关重要.
- 韩国癌症研究小组的老年学得分-7 (KG-7) 是一种用于脆弱性查的新工具.
研究的目的:
- 评估KG-7脆弱查工具在老年多发性骨髓瘤 (MM) 患者中的有效性.
- 确定KG-7是否可以帮助预防该人口群体的治疗不足或过度治疗.
- 评估KG-7在预测生存和治疗毒性方面的能力.
主要方法:
- 一项前性试点队列研究,涉及100名新诊断MM的老年患者 (≥70岁).
- 患者使用KG-7指数进行评估,截止值<5表示脆弱.
- 随访包括平均26.8个月的生存和毒性评估.
主要成果:
- 31%的患者使用KG-7指数被归类为脆弱.
- 在脆弱指数和整体存活率之间没有发现显著的关联.
- 通过KG-7 (和简化脆弱指数) 的脆弱患者显示,3-4级非血液毒性的风险明显更高 (p=0.043).
结论:
- 该KG-7工具有效地识别了老年MM患者,他们面临严重非血液毒性的更高风险.
- 试点研究没有证明KG-7对生存的预测价值.
- 需要进行更大规模的研究来探索KG-7在为老年MM患者量身定制治疗方案中的有用性.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...


